Dr. Paul Greengard, Medical Director of the Fisher Center for Alzheimer’s Disease Research and his colleagues have taken a step in this direction. They have identified a key protein that might help drug makers create pills that alleviate the symptoms of depression faster.
The finding, reported in The Journal of Neuroscience by Dr. Greengard, Dr. Jennifer L. Warner-Schmidt and colleagues in Sweden, gives further credence to the proposition (originally proposed by Greengard and colleagues) that a protein, called p11, is a key player in depressive illness and may lead investigators to new treatments.
Dr. Paul Greengard, Medical Director of the Fisher Center for Alzheimer’s Disease Research and his colleagues have taken a step in this direction. They have identified a key protein that might help drug makers create pills that alleviate the symptoms of depression faster.
The finding, reported in The Journal of Neuroscience by Dr. Greengard, Dr. Jennifer L. Warner-Schmidt and colleagues in Sweden, gives further credence to the proposition (originally proposed by Greengard and colleagues) that a protein, called p11, is a key player in depressive illness and may lead investigators to new treatments.
No hay comentarios:
Publicar un comentario